<DOC>
	<DOC>NCT00875290</DOC>
	<brief_summary>The purpose of this study is to see if the use of a real-time glucose sensor improves diabetes control in young children (less than 4 years old) with Type I diabetes when they are initiated on insulin pump therapy.</brief_summary>
	<brief_title>The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children</brief_title>
	<detailed_description>A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes. After successful screening the subjects will be randomized into one of two groups: a CSII group alone and a CSII group + Real Time Sensor Augmentation group (RTSA) group. The CSII group will serve as the control for the CSII+RTSA group. The trial will last for one year.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Children less than 4 years of age with Type I diabetes for at least 3 months Children greater than 4 years of age Monogenic diabetes</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Diabetes Mellitus, Type I</keyword>
	<keyword>Children</keyword>
	<keyword>Insulin pump therapy</keyword>
	<keyword>Continuous glucose monitor</keyword>
</DOC>